Check patentability & draft patents in minutes with Patsnap Eureka AI!

Synthesis method of pomalidomide intermediate

A technology of pomalidomide and a synthesis method, which is applied in the field of chemical drug synthesis, can solve the problems of low product purity, high toxicity of raw materials, and many impurities, and achieves the effects of high product purity, simple and easy single-step reaction, and environmental protection.

Active Publication Date: 2020-09-18
济南久隆医药科技有限公司
View PDF5 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

It aims to overcome the existing technology (using glutamine as a raw material to undergo Boc reaction to protect the amino group, then react with a condensing agent to cyclize, remove the protecting group, and form a salt with HCL to obtain the product) with long steps, high toxicity of raw materials, and a product made Disadvantages of low purity, many impurities and high cost

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Synthesis method of pomalidomide intermediate
  • Synthesis method of pomalidomide intermediate
  • Synthesis method of pomalidomide intermediate

Examples

Experimental program
Comparison scheme
Effect test

preparation example Construction

[0043] Solution preparation

[0044] Blank solution: take diluting solvent, that is.

Embodiment 1

[0048] (1) Stir and disperse 29.4g of L-glutamic acid in 294g of water, slowly add 8.75g of ammonia water dropwise, keep the temperature below 15°C, and continue to heat and stir for 0.5h after dissolving to form the diammonium salt of L-glutamic acid.

[0049] (2) Heating to 60°C for 2 hours, the diammonium salt of L-glutamic acid removes a molecule of ammonia and cyclizes to form 3-aminopiperidine-2,6-dione, which is precipitated in water.

[0050] (3) Filter and dry at 105°C for 3 hours to obtain 21.4g of 3-aminopiperidine-2,6-dione. Dissolve 21g of 3-aminopiperidine-2,6-dione in 210g of ethanol and pour into the system Introduce hydrochloric acid gas, control the temperature to less than 15°C, until there is no more solid precipitation.

[0051] (4) Filter and dry at 70°C for 3 hours to obtain 27.0 g of the product 3-aminopiperidine-2,6-dione hydrochloride, with a total yield of 82.1% and a purity of 99.76%. (the product obtained in this embodiment uses the high-performan...

Embodiment 2

[0053] (1) Stir and disperse 29.4g of L-glutamic acid in 294g of water, slowly add 7g of ammonia water dropwise, keep the temperature below 15°C, and continue to heat and stir for 0.5h after dissolving to form the diammonium salt of L-glutamic acid.

[0054] (2) Heating to 60°C for 2 hours, the diammonium salt of L-glutamic acid removes a molecule of ammonia and cyclizes to form 3-aminopiperidine-2,6-dione, which is precipitated in water.

[0055] (3) Filter, dry at 105°C for 3 hours to obtain 18g of 3-aminopiperidine-2,6-dione, dissolve 18g of 3-aminopiperidine-2,6-dione in 180g of ethanol, and pass through the system Add hydrochloric acid gas and control the temperature to less than 15°C until no solid is precipitated.

[0056] (4) Filter and dry at 70°C for 3 hours to obtain 27.1 g of the product 3-aminopiperidine-2,6-dione hydrochloride, with a total yield of 82.3% and a purity of 99.35%.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to a synthesis method of a pomalidomide intermediate, and especially relates to a synthesis method of a pomalidomide key intermediate 3-aminopiperidine-2, 6-dione hydrochloride.The method comprises the following steps: reacting a raw material L-glutamic acid with ammonia water to generate diammonium salt of L-glutamic acid, removing monomolecular ammonia gas from the diammonium salt of L-glutamic acid to cyclize to generate 3-aminopiperidine-2, 6-dione, dissolving the 3-aminopiperidine-2, 6-dione in ethanol, introducing hydrochloric acid gas into the system, filtering, and drying to obtain 3-aminopiperidine-2, 6-dione hydrochloride. Toxic and harmful substances are not used in the reaction, and the single-step reaction is simple and easy to carry out.

Description

technical field [0001] The invention belongs to the technical field of chemical drug synthesis, and relates to a synthesis method of a pomalidomide intermediate, in particular to a synthesis of a key intermediate of pomalidomide, 3-aminopiperidine-2,6-dione hydrochloride method. Background technique [0002] Pomalidomide, the chemical name is 3-amino-N-(2,6-dioxo-3-piperidinyl)phthalimide. On January 8, 2013, the US FDA approved it to treat patients with multiple myeloma. [0003] Originating in plasma cells in the bone marrow, multiple myeloma is a malignant blood disease with a high mortality rate. The main clinical manifestations are anemia, bone pain, kidney damage, hypercalcemia, etc. The incidence rate is one in 100,000, and it mostly occurs in the elderly over 50 years old. [0004] The structure of pomalidomide is similar to that of thalidomide, and the structural formula of pomalidomide is as follows: [0005] [0006] Pomalidomide has anti-tumor activity and...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C07D211/88
CPCC07D211/88Y02P20/55
Inventor 马居良殷习栋李志远
Owner 济南久隆医药科技有限公司
Features
  • R&D
  • Intellectual Property
  • Life Sciences
  • Materials
  • Tech Scout
Why Patsnap Eureka
  • Unparalleled Data Quality
  • Higher Quality Content
  • 60% Fewer Hallucinations
Social media
Patsnap Eureka Blog
Learn More

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2025 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com